Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK

Elisabeth Fenwick, Alan Martin, Melanie Schroeder, Stuart J. Mealing, Oyinkansola Solanke, Nancy Risebrough, Afisi S. Ismaila
ERJ Open Research 2021 7: 00480-2020; DOI: 10.1183/23120541.00480-2020
Elisabeth Fenwick
1ICON Health Economics, ICON plc., Abingdon, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Martin
2Value Evidence and Outcomes, GlaxoSmithKline plc., Uxbridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Schroeder
3Value Evidence and Outcomes, GlaxoSmithKline plc., Brentford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart J. Mealing
1ICON Health Economics, ICON plc., Abingdon, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oyinkansola Solanke
4ICON Health Economics, ICON plc., London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Risebrough
5ICON Health Economics, ICON plc., Toronto, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afisi S. Ismaila
6Value Evidence and Outcomes, GlaxoSmithKline plc., Collegeville, PA, USA
7Dept of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: afisi.s.ismaila@gsk.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 1
DOI 
https://doi.org/10.1183/23120541.00480-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received July 8, 2020
  • Accepted November 17, 2020
  • Published online March 22, 2021.

Article Versions

  • previous version (December 10, 2020 - 10:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2021 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Elisabeth Fenwick1,
  2. Alan Martin2,
  3. Melanie Schroeder3,
  4. Stuart J. Mealing1,
  5. Oyinkansola Solanke4,
  6. Nancy Risebrough5 and
  7. Afisi S. Ismaila6,7⇑
  1. 1ICON Health Economics, ICON plc., Abingdon, UK
  2. 2Value Evidence and Outcomes, GlaxoSmithKline plc., Uxbridge, UK
  3. 3Value Evidence and Outcomes, GlaxoSmithKline plc., Brentford, UK
  4. 4ICON Health Economics, ICON plc., London, UK
  5. 5ICON Health Economics, ICON plc., Toronto, ON, Canada
  6. 6Value Evidence and Outcomes, GlaxoSmithKline plc., Collegeville, PA, USA
  7. 7Dept of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
  1. Afisi S. Ismaila, GlaxoSmithKline plc., 1250 South Collegeville Road, Collegeville, PA 19426-0989, USA. E-mail: afisi.s.ismaila{at}gsk.com
View Full Text

Funding

  • GlaxoSmithKline plc.

Article usage

Article usage: December 2020 to November 2023

AbstractFullPdf
Dec 2020524024
Jan 2021453519
Feb 2021174530
Mar 2021939962
Apr 20212117063
May 2021911538
Jun 2021812133
Jul 2021312136
Aug 2021811028
Sep 202117737
Oct 2021810041
Nov 202195735
Dec 202134815
Jan 202253923
Feb 202254921
Mar 202244919
Apr 202247733
May 202235423
Jun 202216019
Jul 202253919
Aug 2022105327
Sep 202257435
Oct 2022104626
Nov 202243814
Dec 202205021
Jan 202355832
Feb 202365118
Mar 202344716
Apr 202353227
May 2023115020
Jun 202375117
Jul 202364832
Aug 202314513
Sep 202394715
Oct 202356111
Nov 2023910924

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
Elisabeth Fenwick, Alan Martin, Melanie Schroeder, Stuart J. Mealing, Oyinkansola Solanke, Nancy Risebrough, Afisi S. Ismaila
ERJ Open Research Jan 2021, 7 (1) 00480-2020; DOI: 10.1183/23120541.00480-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
Elisabeth Fenwick, Alan Martin, Melanie Schroeder, Stuart J. Mealing, Oyinkansola Solanke, Nancy Risebrough, Afisi S. Ismaila
ERJ Open Research Jan 2021, 7 (1) 00480-2020; DOI: 10.1183/23120541.00480-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Characteristics and impact of EILO
  • A common model for the breathlessness experience
  • Endobronchial autologous BM-MSCs in IPF patients
Show more Original articles

COPD

  • A bronchial gene signature specific for severe COPD
  • Undiagnosed major cardiac comorbidities in COPD
  • Association of weather with variability in PA in COPD
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society